Invesco Ltd. Grows Holdings in STERIS plc (NYSE:STE)

Invesco Ltd. lifted its holdings in STERIS plc (NYSE:STE - Free Report) by 9.3% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,022,479 shares of the medical equipment provider's stock after purchasing an additional 87,215 shares during the period. Invesco Ltd. owned about 1.04% of STERIS worth $210,181,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in STE. Avalon Trust Co purchased a new position in shares of STERIS during the 4th quarter worth $30,000. Human Investing LLC bought a new position in STERIS in the 4th quarter worth $31,000. Anfield Capital Management LLC lifted its position in STERIS by 100.0% during the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock valued at $37,000 after purchasing an additional 91 shares in the last quarter. Central Pacific Bank Trust Division grew its holdings in STERIS by 65.5% during the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock valued at $39,000 after purchasing an additional 76 shares during the period. Finally, Manchester Capital Management LLC raised its stake in shares of STERIS by 182.7% in the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock worth $44,000 after buying an additional 137 shares during the period. Hedge funds and other institutional investors own 94.69% of the company's stock.

STERIS Price Performance

STERIS stock traded up $3.29 during midday trading on Thursday, reaching $223.31. 104,758 shares of the stock traded hands, compared to its average volume of 529,294. The stock has a market cap of $21.94 billion, a P/E ratio of 47.37 and a beta of 0.87. STERIS plc has a 12 month low of $197.82 and a 12 month high of $248.24. The stock's fifty day moving average is $222.53 and its 200-day moving average is $219.42. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32.

STERIS (NYSE:STE - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. As a group, equities research analysts anticipate that STERIS plc will post 9.08 EPS for the current year.

STERIS Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 21st. Stockholders of record on Thursday, February 20th were paid a $0.57 dividend. This represents a $2.28 annualized dividend and a dividend yield of 1.02%. The ex-dividend date was Thursday, February 20th. STERIS's dividend payout ratio is currently 48.41%.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the stock. JMP Securities reissued a "market outperform" rating and issued a $265.00 target price on shares of STERIS in a report on Thursday, April 10th. Piper Sandler raised their price objective on shares of STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research report on Monday, February 3rd. Stephens reissued an "overweight" rating and set a $240.00 price target on shares of STERIS in a report on Thursday, February 6th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of STERIS in a research report on Monday, April 7th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.